cbdMD, Inc. (YCBD)
NYSEAMERICAN: YCBD · Real-Time Price · USD
0.7201
-0.0298 (-3.97%)
At close: Sep 4, 2025, 4:00 PM
0.7020
-0.0181 (-2.51%)
Pre-market: Sep 5, 2025, 8:15 AM EDT
cbdMD Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2020 |
| 19.03 | 19.48 | 24.16 | 35.4 | 44.48 | 41.88 | Upgrade | |
Revenue Growth (YoY) | -7.80% | -19.35% | -31.77% | -20.41% | 6.20% | 77.09% | Upgrade |
Cost of Revenue | 7.38 | 7.49 | 9.18 | 13.07 | 14.5 | 15.51 | Upgrade |
Gross Profit | 11.64 | 12 | 14.98 | 22.34 | 29.99 | 26.37 | Upgrade |
Selling, General & Admin | 11.91 | 13.27 | 18.93 | 33.29 | 43.37 | 38.83 | Upgrade |
Research & Development | 0.04 | 0.04 | 0.17 | 0.63 | 1.42 | 0.42 | Upgrade |
Other Operating Expenses | 0.33 | 0.86 | 3.34 | 3.89 | 3.79 | 3.97 | Upgrade |
Operating Expenses | 13.44 | 15.31 | 24.25 | 39.65 | 49.6 | 43.95 | Upgrade |
Operating Income | -1.79 | -3.32 | -9.27 | -17.31 | -19.62 | -17.58 | Upgrade |
Interest Expense | - | -0.03 | - | - | -0.03 | - | Upgrade |
Interest & Investment Income | 0.03 | - | 0.06 | 0.02 | - | 0.04 | Upgrade |
Other Non Operating Income (Expenses) | - | - | - | 0.24 | 0.03 | - | Upgrade |
EBT Excluding Unusual Items | -1.76 | -3.34 | -9.2 | -17.06 | -19.62 | -17.54 | Upgrade |
Merger & Restructuring Charges | - | - | - | -0.6 | - | - | Upgrade |
Impairment of Goodwill | - | - | - | -56.67 | - | - | Upgrade |
Gain (Loss) on Sale of Investments | - | - | -0.7 | -0.03 | 0.55 | -0.93 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | 0.09 | - | - | Upgrade |
Asset Writedown | - | - | -13.22 | -4.29 | - | - | Upgrade |
Other Unusual Items | 0.25 | -0.36 | 0.19 | 8.47 | -5.22 | 29.78 | Upgrade |
Pretax Income | -1.51 | -3.7 | -22.94 | -70.08 | -24.29 | 11.31 | Upgrade |
Income Tax Expense | - | - | - | - | -0.9 | -1.35 | Upgrade |
Earnings From Continuing Operations | -1.51 | -3.7 | -22.94 | -70.08 | -23.39 | 12.65 | Upgrade |
Earnings From Discontinued Operations | - | - | - | - | - | -0.05 | Upgrade |
Net Income | -1.51 | -3.7 | -22.94 | -70.08 | -23.39 | 12.6 | Upgrade |
Preferred Dividends & Other Adjustments | 3.34 | 4 | 4 | 4 | 2.55 | 0.37 | Upgrade |
Net Income to Common | -4.85 | -7.7 | -26.94 | -74.09 | -25.95 | 12.24 | Upgrade |
Shares Outstanding (Basic) | 2 | 1 | 0 | 0 | 0 | 0 | Upgrade |
Shares Outstanding (Diluted) | 2 | 1 | 0 | 0 | 0 | 0 | Upgrade |
Shares Change (YoY) | 510.60% | 113.25% | 52.31% | 8.76% | 21.62% | 152.53% | Upgrade |
EPS (Basic) | -2.40 | -14.29 | -106.57 | -446.37 | -170.04 | 99.79 | Upgrade |
EPS (Diluted) | -2.41 | -14.32 | -106.57 | -446.40 | -170.04 | 99.79 | Upgrade |
Free Cash Flow | -1.24 | -0.54 | -4.6 | -15.66 | -14.44 | -11.98 | Upgrade |
Free Cash Flow Per Share | -0.61 | -1.01 | -18.20 | -94.33 | -94.59 | -95.51 | Upgrade |
Gross Margin | 61.20% | 61.57% | 62.01% | 63.09% | 67.41% | 62.96% | Upgrade |
Operating Margin | -9.43% | -17.02% | -38.37% | -48.89% | -44.10% | -41.98% | Upgrade |
Profit Margin | -25.50% | -39.55% | -111.53% | -209.26% | -58.34% | 29.21% | Upgrade |
Free Cash Flow Margin | -6.49% | -2.79% | -19.04% | -44.22% | -32.45% | -28.61% | Upgrade |
EBITDA | -0.64 | -2.17 | -7.47 | -15.48 | -18.6 | -16.86 | Upgrade |
EBITDA Margin | -3.37% | -11.12% | -30.92% | -43.72% | -41.81% | -40.26% | Upgrade |
D&A For EBITDA | 1.15 | 1.15 | 1.8 | 1.83 | 1.02 | 0.72 | Upgrade |
EBIT | -1.79 | -3.32 | -9.27 | -17.31 | -19.62 | -17.58 | Upgrade |
EBIT Margin | -9.43% | -17.02% | -38.37% | -48.89% | -44.10% | -41.98% | Upgrade |
Revenue as Reported | 19.03 | 19.48 | 24.16 | 35.4 | 44.48 | 41.88 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.